No Data
No Data
Express News | Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Benign Growth For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Underpins Stock's 26% Plummet
Express News | Rigel Announces Settlement Agreement Resolving Tavalisse® (Fostamatinib Disodium Hexahydrate) Patent Litigation
Rigel Announces Settlement Agreement Resolving TAVALISSE (Fostamatinib Disodium Hexahydrate) Patent Litigation
Statutory Profit Doesn't Reflect How Good Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are